Literature DB >> 12435966

Post hoc mortality analysis on the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock.

C Gillon Ward, Edward P Sloan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12435966     DOI： 10.1097/01.TA.0000032079.45859.09

Source DB:  PubMed          Journal:  J Trauma        ISSN： 0022-5282


× No keyword cloud information.
  1 in total

1.  The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents.

Authors:  Edward P Sloan
Journal:  Intensive Care Med       Date:  2003-03       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.